Microsoft executive Diana Pallais is an experienced business leader and social innovator

Awardees will generate evidence on best ways to improve maternal, child nutrition

PATH receives two Grand Challenges Explorations grants to advance a new class of cold chain equipment and simplify human milk banking systems

New collaboration between PATH and the Population Council will strengthen and scale up programs through implementation science

PATH staff will highlight our work to leverage new approaches and tools in the fight against malaria

PATH staff will highlight our work to advance technologies and approaches that expand family planning access and choices

Award recognizes extraordinary role in advancing PATH’s work

PATH staff will share expertise in tuberculosis prevention, diagnosis, treatment, and care

Ashley Birkett, PhD, to lead key product development program at PATH

Milestone marks the first prequalified JE vaccine for children and the first Chinese vaccine manufacturer to achieve prequalification

PATH staff will highlight our work in malaria control, treatment, and vaccine development

Development of long-acting injectable drug could reduce the risk of infection in healthy adults

Breakthrough health innovations could save 1.2 million mothers and children by the end of 2015

Panel discussion in Seattle features work by PATH and others to save lives and strengthen communities through better reproductive health

Study in The Lancet shows remarkable effectiveness of vaccine developed through a PATH-WHO partnership

International conference showcases recent innovations in skin-mediated vaccination advanced by PATH and partners

UK government is funding nine innovative partnerships to address deadly diseases

Four proposed products answer a challenge to find smart solutions to protect women and newborns worldwide

PATH will lead five-year, multi-million dollar initiative aimed at creating transformative impact to increase immunization coverage

Visit and tour spark discussion on innovative public-private partnerships and the state’s burgeoning global health sector

PATH’s work helps pave the way for broad use of chlorhexidine to prevent deadly neonatal infections

Ashley Birkett appointed deputy director of PATH’s Malaria Vaccine Initiative

Standard Diagnostics will manufacture point-of-care test for onchocerciasis developed by PATH

The device is safe, comfortable, and easy to use, expanding nonhormonal contraceptive options for women

Proven leader in finance, business, and nonprofit sectors to direct PATH’s financial operations

Innovation in Motion explores transformative innovations to address diarrheal disease, pneumonia, family health, malaria, and more

Panel at the World Health Assembly sets stage for global action

Research and analysis shows global collaboration using continuum of care approach and nonpneumatic antishock garment to address postpartum hemorrhage has positive results

The four winning entries debuted at the Women Deliver 2013 conference

Investigational new drug developed by PATH’s Drug Development program could shorten the duration and severity of symptoms

International conference will showcase how PATH takes innovation to scale to save women’s lives

Partners announce positive phase 3 clinical trial results for affordable rotavirus vaccine

First non-plant-derived source of a key ingredient in the top malaria drug will increase access to treatment

Advances in oral rehydration solution composition may strengthen a proven defense against diarrhea

Leader with international, multisector experience to guide and strengthen PATH’s operating systems

Dose-reduction strategies could help conserve 420 million doses of yellow fever vaccine by 2022, new report concludes